Penserra Capital Management LLC Seelos Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

  • $7.9 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.51 - $0.93 $15,443 - $28,162
-30,282 Reduced 8.11%
343,215 $233,000
Q1 2022

May 13, 2022
BUY
$0.84 - $1.71 $44,880 - $91,363
53,429 Added 16.69%
373,497 $235,000
Q4 2021

Feb 15, 2022
BUY
$1.59 - $2.38 $96,843 - $144,961
60,908 Added 23.5%
320,068 $521,000
Q3 2021

Nov 15, 2021
BUY
$1.69 - $2.89 $263,104 - $449,923
155,683 Added 150.45%
259,160 $624,000
Q2 2021

Aug 12, 2021
BUY
$2.64 - $6.32 $273,179 - $653,974
103,477 New
103,477 $273,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $109M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email